By Indication

Sentinel Lymph Node Biopsy (SLNB) Guidance Market Analysis

Cross-industry research covering Sentinel Lymph Node Biopsy (SLNB) Guidance across 1 market reportspanning Medical Devices & Surgical Navigation.

1 Reports

1 Industries

Reports Covering Sentinel Lymph Node Biopsy (SLNB) Guidance

Breast Lesion Localization Methods Market to Reach USD 1.42B by 2033 at 8.3% CAGR

Medical Devices & Surgical Navigation·Market: USD 0.74 Billion (2025)·CAGR: 8.3%

While SLNB is primarily a separate procedure, combined localization of the primary lesion and the sentinel node is increasingly performed as a single preoperative step, using dual-tracer or magnetic approaches. Sirius Medical's CANOpus system (nct:NCT06950021) specifically includes lymph node excision as a labeled indication.

11%

Market Share

8.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments